Jane Dancer

Jane Dancer has an extensive work experience in the biotechnology industry. Jane began their career in 2000 as a Global Project Manager at Aventis CropScience. In 2002, they joined Cambridge Antibody Technology/AstraZeneca as a Director of Business Development and was part of the negotiation team for the strategic collaboration with AstraZeneca established in 2004. In 2008, they became Vice President of Business Development at Cellzome and was responsible for the alliance management of two significant collaborations with GSK which led to the acquision of Cellzome by GSK in May 2012. From 2012 to 2018, Jane was a Business Development Consultant and Chief Business Officer at F-star Biotechnology Ltd. Jane also held Non Executive Director positions at NanoSyrinx, Macomics, PharmEnable, and the BioIndustry Association. Currently, Jane is a Non Executive Director at Elasmogen Ltd.

Jane Dancer attended the University of Cambridge from 1981 to 1987, where they earned a BA in Natural Science, First Class in 1984, a Doctor of Philosophy - PhD in Plant Biochemistry in 1987, and an MBA in 2002.